- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05056766
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement (OAMMM)
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolve According to Propulsion: Control With Each mm of Advancement"
The OAMMM study is a mono-centrer , non interventional, prospective study, carried out in CH Valence
Oral Appliance is indicated for first line moderate sleep Apnea Syndrome or severe sleep Apnea Syndrome after failure of positive airway pressure (CPAP).
Clinical impact of each mm advancement of Oral Appliance is imperfectly assessed.
The study aim to assess clinical and paraclinical efficacy of an oral Appliance on each mm of advancement.
Study Overview
Status
Intervention / Treatment
Detailed Description
Oral appliance will be delivered with a propulsion at 50% of the maximum advance and the investigator will titrate the advance according to the usual method
Polygraphy and clinical effectiveness of the Oral appliance will be evaluate
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Valence, France, 26953
- Ch Valence
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years old
- Moderate sleep apnea diagnosis with clinical signs
- Severe sleep apnea with failure continuous positive airway pressure( CPAP)
Exclusion Criteria:
- previous sleep apnea treatment for Moderate sleep apnea
- refusal to participate in research
- Patient under guardianship, deprived of liberty, safeguard of justice
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
single group assignement
|
Each patient will undergo 3 to 7 polygraphy recordings according usual practice of titration At the same time, Self-questionnaires will be conducted by the patient in order to evaluate Oral appliance efficacy. Optimal titration of oral appliance will be done according subjectives parameters. (sleepeness Reduction and fatigue Reduction). Neither the investigator nor the patient will know the polygraphy results (apnea-hypopnea index) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
apnea-hypopnea index
Time Frame: 6 months
|
severity of sleep apnea
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Epworth Sleepiness Scale score
Time Frame: 6 months
|
6 months
|
pichot fatigue questionnaire
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Guillaume BUIRET, MD, Ch Valence
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Tract Diseases
-
Vakzine Projekt Management GmbHFGK Clinical Research GmbHUnknownInfection, Respiratory TractGermany
-
University of Colorado, DenverBiofireCompletedAcute Respiratory Infection | Lower Respiratory Tract Illness | Respiratory Pathogens | Upper Respiratory Tract IllnessUnited States
-
Zambon SpACompleted
-
Direction Centrale du Service de Santé des ArméesRecruitingRespiratory Tract Infections | Respiratory Tract DiseaseFrance
-
PfizerCompletedRespiratory Tract InfectionUnited States, New Zealand, Chile, Argentina, South Africa
-
GlaxoSmithKlineCompletedInfections, Respiratory TractUnited States
-
AbbottEilafCompletedRespiratory Tract InfectionEgypt, Saudi Arabia
-
University of MontanaNational Institute of Environmental Health Sciences (NIEHS)CompletedLower Tract Respiratory InfectionUnited States
-
PfizerCompletedRespiratory Tract InfectionUnited States, Netherlands, Spain, Korea, Republic of, Denmark, Taiwan, Australia, Mexico, Canada, Japan, Finland, Argentina, Brazil, Chile, Gambia, New Zealand, Philippines, South Africa
-
GlaxoSmithKlineCompletedInfections, Respiratory TractUnited States
Clinical Trials on questionnaires: Epworth Sleepiness Scale; Pichot fatigue questionnaire.
-
Atatürk Chest Diseases and Chest Surgery Training...Completed
-
City Hospitals Sunderland NHS Foundation TrustCompletedPregnancy | Obstructive Sleep ApnoeaUnited Kingdom
-
Centre Hospitalier Universitaire, AmiensCompletedObstructive Sleep Apnea SyndromeFrance
-
Hospices Civils de LyonRecruitingHypersomnia | Sleepiness, Excessive DaytimeFrance
-
Duke UniversityCompletedSleep Apnea, Obstructive | Pregnancy | Obesity, MorbidUnited States
-
MetroHealth Medical CenterActive, not recruitingGastro Esophageal RefluxUnited States
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingHealthy VolonteersFrance
-
Medical University of LodzUnknownObstructive Sleep Apnea | Chronic Kidney Disease | Acute Kidney FailurePoland
-
Assistance Publique - Hôpitaux de ParisCompletedExcessive Daytime SleepinessFrance